Mps Loria Financial Planners, LLC Alaunos Therapeutics, Inc. Transaction History

Mps Loria Financial Planners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 20, 2021	SELL	$2.63 - $3.67 $1,357 - $1,893	-516 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$2.2 - $3.71 $1,135 - $1,914	516 New	516 $2,000
Q3 2017 Oct 24, 2017	SELL	$4.99 - $6.57 $9,061 - $11,931	-1,816 Closed	0 $0
Q2 2017 Sep 18, 2017	BUY	N/A	1,816	1,816 $10,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $607M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Mps Loria Financial Planners, LLC, based on Form 13F filings with the SEC.

Stay updated on Mps Loria Financial Planners, LLC with notifications on news.